Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary

NCT02590055 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma of Unknown Primary

Interventions

DRUG: gemcitabine/docetaxel combination

Sponsor

Samsung Medical Center